Pharmacokinetic Difference of Six Active Constituents of Huangqi Liuyi Decoction between Control and Diabetic Nephropathy Mouse Models

Huangqi Liuyi decoction is a famous traditional Chinese medicine (TCM) that has been widely used in China for the management of diabetes since the Song Dynasty. Today, it is commonly used for treating diabetic nephropathy (DN). Our previous experimental studies have suggested that the mixture HQD, c...

Full description

Saved in:
Bibliographic Details
Published in:International journal of analytical chemistry 2022-05, Vol.2022, p.7602992-13
Main Authors: Wang, Qun, Shi, Ya, Liu, Xingde, Liu, Ting, Li, Yongjun, Song, Xinli, Chen, Xiaolan, Jin, Yang, Liu, Wen, Wang, Yonglin, Gong, Zipeng
Format: Article
Language:English
Subjects:
Acids
Active control
Analytical chemistry
Calibration
Chinese medicine
Chromatography
Constituents
Diabetes
Diabetes therapy
Diabetic nephropathies
Diabetic nephropathy
High performance liquid chromatography
Kidney diseases
Mass spectrometry
Medicine, Chinese
Oral administration
Pharmacokinetics
Pharmacology
Plasma
Polysaccharides
Quality control
Quality standards
Renal function
Saponins
Traditional Chinese medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Huangqi Liuyi decoction is a famous traditional Chinese medicine (TCM) that has been widely used in China for the management of diabetes since the Song Dynasty. Today, it is commonly used for treating diabetic nephropathy (DN). Our previous experimental studies have suggested that the mixture HQD, containing astragalus saponin, astragalus flavone, astragalus polysaccharide, and glycyrrhetinic acid, could be used for the treatment of DN and to improve renal function. The objective of this study was to develop a sensitive and reliable high-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantitation of astragaloside IV, calycosin-7-O-β-D-glucoside, calycosin-glucuronide, ononin, formononetin, and glycyrrhizic acid, which are the main active constituents in HQD, and to compare the pharmacokinetics of these active constituents in control and DN mice orally treated with HQD. The results indicated that the pharmacokinetic parameters of HQD were significantly different between the control and DN mouse groups. The absorption of HQD in the DN mice was greater than that in control mice.
ISSN:1687-8760
1687-8779
DOI:10.1155/2022/7602992